Cas No.: | 1965261-97-5 |
Chemical Name: | 7-chloro-3-(2-(6-cyclopropyl-1H-indol-3-yl)-2-oxoethoxy)-2-naphthamide |
Synonyms: | SPR-00305 potently inhibited the MvfR pathway with IC50s of 115 nM against 4-hydroxy-2-heptylquinoline (HHQ), 93 nM against pyocyanin (PYO) and 109 nM against 3,4-dihydroxy-2-heptoquinoline (PQS) in PA14. |
SMILES: | C1=C2C(C=CC(Cl)=C2)=CC(OCC(C2C3=C(NC=2)C=C(C2CC2)C=C3)=O)=C1C(N)=O |
Formula: | C24H19ClN2O3 |
M.Wt: | 418.877 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | SPR-00305 is a potent MvfR inhibitor and displays target engagement. SPR-00305, potently inhibited the MvfR pathway with IC50s of 115 nM against 4-hydroxy-2-heptylquinoline (HHQ), 93 nM against pyocyanin (PYO) and 109 nM against 3,4-dihydroxy-2-heptoquinoline (PQS) in PA14. The compound was further tested in the immunocompetent acute thigh infection model. It decreased PQS by 50% and HHQ by 40% in comparison with vehicle. In the neutropenic acute thigh infection model, SPR-00305 oral administration (200 mg) resulted in a slight decrease in HHQ levels. |